Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -0.47% | -5.41% | 0.00% |
04-01 | Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-26 | Transcript : Quince Therapeutics, Inc. - Special Call |
Business Summary
Number of employees: 32
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dirk Thye
CEO | Chief Executive Officer | 54 | 18/05/22 |
Brendan Hannah
DFI | Director of Finance/CFO | 39 | 30/04/22 |
Charles Ryan
PSD | President | 60 | 31/08/23 |
Maureen M. Roden
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/22 |
Stacy Roughan
IRC | Investor Relations Contact | - | - |
Gary Ward
PRN | Corporate Officer/Principal | - | 31/07/22 |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Una Ryan
BRD | Director/Board Member | 82 | 28/02/18 |
Luca Benatti
BRD | Director/Board Member | 63 | 22/10/23 |
Dirk Thye
CEO | Chief Executive Officer | 54 | 18/05/22 |
David Lamond
CHM | Chairman | 49 | 30/11/15 |
Rajiv Patni
BRD | Director/Board Member | 55 | 02-14 |
Director/Board Member | 56 | 28/02/19 | |
Director/Board Member | 61 | 30/11/15 | |
June Bray
BRD | Director/Board Member | 70 | 08/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,215,233 | 35,841,506 ( 82.94 %) | 0 | 82.94 % |
Company contact information
Quince Therapeutics, Inc.
611 Gateway Boulevard Suite 273
94080, South San Francisco
+
http://quincetx.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 45.59M | |
+0.96% | 42.86B | |
+13.63% | 42.74B | |
+44.98% | 41.36B | |
-6.20% | 27.68B | |
+6.54% | 25.15B | |
-23.50% | 18.63B | |
+29.55% | 12.37B | |
-2.92% | 11.92B | |
+7.11% | 11.21B |
- Stock Market
- Equities
- QNCX Stock
- Company Quince Therapeutics, Inc.